Serum Institute Seeks Govt Nod To Manufacture Sputnik V In India
Indigenous vaccine-maker Serum Institute of India on June 2 requested the DCGI to grant approval for manufacturing of Russia's COVID-19 vaccine Sputnik V in India. The company has also applied for conducting clinical trials of the vaccine. While six Indian companies are already in an agreement to manufacture the vaccine, SII will be the seventh one to join the league. Currently, Dr Reddy's Laboratories is manufacturing Sputnik V in India.